IRIS
BALDARI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 29.830
NA - Nord America 25.008
AS - Asia 12.585
SA - Sud America 4.146
Continente sconosciuto - Info sul continente non disponibili 746
AF - Africa 412
OC - Oceania 35
Totale 72.762
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.286
RU - Federazione Russa 13.101
IT - Italia 5.655
SG - Singapore 5.159
BR - Brasile 3.545
CN - Cina 3.502
IE - Irlanda 3.091
SE - Svezia 2.937
HK - Hong Kong 1.287
DE - Germania 1.221
FR - Francia 834
VN - Vietnam 828
FI - Finlandia 635
GB - Regno Unito 632
IN - India 562
UA - Ucraina 529
NL - Olanda 394
CA - Canada 296
PL - Polonia 228
BD - Bangladesh 194
AR - Argentina 191
TR - Turchia 141
MX - Messico 135
IQ - Iraq 133
ZA - Sudafrica 119
BE - Belgio 110
JP - Giappone 94
CO - Colombia 89
ES - Italia 83
AT - Austria 82
EC - Ecuador 81
ID - Indonesia 79
CZ - Repubblica Ceca 74
PK - Pakistan 73
UZ - Uzbekistan 64
VE - Venezuela 62
CL - Cile 60
MA - Marocco 58
CR - Costa Rica 55
IL - Israele 51
TN - Tunisia 49
CI - Costa d'Avorio 44
IR - Iran 41
AE - Emirati Arabi Uniti 40
LT - Lituania 40
SA - Arabia Saudita 40
JM - Giamaica 39
PY - Paraguay 37
AZ - Azerbaigian 36
PH - Filippine 35
HN - Honduras 34
KE - Kenya 34
PE - Perù 31
CH - Svizzera 29
AU - Australia 28
EG - Egitto 27
UY - Uruguay 26
MY - Malesia 24
DZ - Algeria 23
PA - Panama 22
JO - Giordania 21
KG - Kirghizistan 21
PR - Porto Rico 21
SV - El Salvador 21
TT - Trinidad e Tobago 21
NI - Nicaragua 20
NP - Nepal 20
AL - Albania 19
EU - Europa 19
GT - Guatemala 19
KZ - Kazakistan 19
SC - Seychelles 19
BO - Bolivia 18
PS - Palestinian Territory 16
RO - Romania 16
GP - Guadalupe 15
LB - Libano 15
GE - Georgia 14
OM - Oman 13
CW - ???statistics.table.value.countryCode.CW??? 12
PT - Portogallo 12
DO - Repubblica Dominicana 11
NO - Norvegia 11
AM - Armenia 10
BG - Bulgaria 10
BY - Bielorussia 10
EE - Estonia 9
HU - Ungheria 9
SN - Senegal 9
BH - Bahrain 8
GR - Grecia 8
HR - Croazia 7
LK - Sri Lanka 7
LV - Lettonia 7
TH - Thailandia 7
XK - ???statistics.table.value.countryCode.XK??? 7
DK - Danimarca 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
KW - Kuwait 5
Totale 71.953
Salva come PNG Salva come JPEG
Città #
Moscow 3.864
Ashburn 3.580
Dublin 3.079
Singapore 2.656
Dallas 2.488
Chandler 2.474
Nyköping 1.665
San Jose 1.618
Hong Kong 1.282
Beijing 1.271
Jacksonville 1.182
Council Bluffs 720
The Dalles 612
Los Angeles 535
Princeton 511
Milan 474
Medford 472
Munich 459
Rome 429
Lauterbourg 427
Dearborn 406
Cambridge 366
Des Moines 360
New York 360
Ann Arbor 337
Messina 331
São Paulo 283
Dong Ket 236
Boardman 235
Hyderabad 215
Buffalo 212
Naples 193
Ho Chi Minh City 192
Warsaw 187
Santa Clara 170
Bremen 164
Jinan 151
Lancaster 149
Tianjin 148
Wilmington 141
Turku 136
Redondo Beach 129
Hanoi 128
Helsinki 124
Shenyang 123
Pune 121
Orem 112
Palermo 107
Brussels 104
Catania 104
Turin 104
Frankfurt am Main 101
Woodbridge 100
Guangzhou 96
Houston 95
San Mateo 92
Atlanta 91
Montreal 89
Rio de Janeiro 89
Phoenix 88
Bologna 87
Brasília 84
Bari 83
Belo Horizonte 83
Brooklyn 83
Chicago 77
Nanjing 76
Tokyo 76
Denver 73
Florence 73
Johannesburg 71
Chennai 70
Seattle 68
Curitiba 65
London 65
Genoa 64
Zhengzhou 62
Porto Alegre 61
Vienna 59
Baghdad 57
Stockholm 57
Tashkent 57
Columbus 55
Nuremberg 54
Hebei 52
Nanchang 51
Ningbo 50
North Bergen 50
Amsterdam 49
Campinas 49
Toronto 49
Hangzhou 47
Shanghai 46
Abidjan 44
Brno 43
Washington 42
Haikou 41
Manchester 41
San José 40
Poplar 39
Totale 39.160
Salva come PNG Salva come JPEG
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 4.755
111In-Pentetreotide in neuroendocrine tumours. Comparison between diagnostic scintigraphy and “post-therapy” whole-body scan 336
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA. 335
153Sm-EDTMP in the treatment of painful bone metastases from prostate and breast cancer. Personal experience. 298
Aggressive pituitary adenomas: the dark side of the moon 293
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 290
153Sm-EDTMP in the treatment of painful bone metastases from breast cancer. 286
186Re-HEDP in the treatment of painful bone metastases from cancers other than prostate and breast 285
Value of 99mTc-DPD scintigraphy as early diagnostic modality in familial amyloidotic polyneuropathy. 282
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 267
18F-FDG PET/CT in overweight patients using a TOF LYSO PET/CT scanner: comparison of different acquisition times. 264
Acute effects of propafenone on left ventricular function in myocardial infarction 259
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 257
PRE- AND POSTOPERATIVE CEREBRAL PERFUSION ASSESSMENTS IN CHRONIC SUBDURAL HEMATOMA 251
111In-Pentetreotide for treatment of neuroendocrine tumours: an alternative therapeutic option in particular cases 249
Abscesualized gliomas:predictive value of 99Tc-Leukoscan 247
[68 Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177 Lu]DOTATOC PRRT: The “Theragnomics” Concept 246
111In-Pentetreotide in neuroendocrine tumours: comparison between diagnostic scintigraphy and “post-therapy” whole-body scan 241
Ruolo dell'imaging funzionale nel management delle emorragie cerebrali atipiche: proposta di un protocollo diagnostico derivato dalla sperimentazione clinica. 240
Combined diagnosis in breast carcinoma: preoperative role of mammoscintigraphy with Tc99m-sestamibi. Our Experience 236
Ruolo della scintigrafia con HIG 99mTc (immunoglobuline policlonali marcate) nella colite ulcerosa e nel morbo di Crohn. Risultati preliminari 235
2D Feature Strain Echocardiography in patients with transthyretin familial amyloid plyneuropathy and diffuse cardiac 99mTc-DPD accumulation 231
99mTc-MIBI SPECT in distinguishing neoplastic from nonneoplastic intracerebral hematoma 229
111In-Pentetreotide therapy in patients with inoperable benign intracranial tumors. 228
18F-FDG PET/CT Imaging of Prostate Stromal Tumor of Uncertain Malignant Potential 225
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 215
A didactic experiment showing the Compton scattering by means of a clinical gamma camera 215
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 213
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 212
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 211
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy 211
99mTc MIBI SPET in revealing underlying neoplasms in brain hemorrhages 210
99mTc-HM-PAO SPECT evaluation of regional cerebral blood flow modifications after paediatric hydrocephalus shunting 210
18F-FDG PET/CT Imaging of Immune Checkpoint Inhibitor-Related "Retroperitoneal Panniculitis" 210
99mTc-MIBI SPECT in the differential diagnosis of brain metastases 208
Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: report of a case and review of the literature 208
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 207
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 206
11C-Choline PET/CT based helical tomotherapy as innovative treatment approach for bone metastases in prostate cancer patients 206
PRRT Retreatments: Renal Function Evaluation 206
An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule 205
Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy? 205
Association of parathyroid carcinoma and thyroid disorders: A clinical review 204
99mTc-MIBI SPECT imaging of acute and subacute non-neoplastic brain haematomas 203
223RA-dichloride use in patients affected by bone metastases from castration-resistant prostate cancer: single centre experience 203
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 200
ABLAZIONE RADIOMETABOLICA DEL RESIDUO TIROIDEO POST-CHIRURGICO DOPO STIMOLO CON TSH UMANO RICOMBINANTE (rhTSH) IN PAZIENTI CON OFTALMOPATIA DI GRAVES (OG) DI GRADO MODERATAMENTE SEVERO E SEVERO: STUDIO PROSPETTICO RANDOMIZZATO IN SINGOLO CIECO 199
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 198
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 198
18F-FACBC in prostate cancer: A systematic review and meta-analysis 198
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 197
90Y-dotatoc and/or 111In-pentetreotide in the treatment of somatostatin receptors-expressing tumors (SSTR): personal experience 196
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 195
Constrictive Pericarditis: An Update on Noninvasive Multimodal Diagnosis 194
Erratum: Mid and long-term effects on pulmonary perfusion, anatomy and diaphragamatic motility in survivors of congenital diaphragmatic hernia 194
Diagnostic possibilities and clinical indications of policlonal labeled Ig in the bowel inflammatory disease 193
[(186)Re]HEDP in the palliation of painful bone metastases from cancers otherthan prostate and breast. 192
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 192
Comparison Between 99mTc-Diphosphonate Imaging and MRI With Late Gadolinium Enhancement in Evaluating Cardiac Involvement in Patients With Transthyretin Familial Amyloid Polyneuropathy 192
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 192
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 191
Abnormal radioiodine uptake in an abdominal dermoid cyst in a patient affected by differentiated thyroid cancer 191
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 190
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 190
An extremely rare association of TSH-secreting pituitary adenoma, metastatic neuroendocrine tumor and Cushing’s syndrome in a patient with MEN-1 gene mutation 190
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 188
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 188
GASTROINTESTINAL SEQUELAE IN SURVIVORS OF CONGENITAL DIAPHRAGMATIC HERNIA 187
Diagnosis of hepatic hemangiomas with 99mTc-labeled red blood cell scanning: value of SPECT 187
A methodological approach to a realistic evaluation of skin absorbed doses during manipulation of radioactive sources by means of GAMOS Monte Carlo simulations 187
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 187
SPECT and MRI in Complex Partial Epilepsy. 186
Brunner's adenoma, esophageal reflux and gastric ulcer. A case report 186
A Monte Carlo approach to small-scale dosimetry of solid tumour microvasculature for nuclear medicine therapies with (223)Ra-, (131)I-, (177)Lu- and (111)In-labelled radiopharmaceuticals 186
Usefulness of PET-CT scan in recurrent thyroid cancer 186
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot 186
11c-choline pet/ct based helical tomotherapy as treatment approach for bone metastases in recurrent prostate cancer patients 185
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer 184
A Monte Carlo model for the internal dosimetry of choroid plexuses in nuclear medicine procedures 184
COVID-19 Surface Persistence: A Recent Data Summary and Its Importance for Medical and Dental Settings 184
A microdosimetric model of solid tumour microvasculature for radiopharmaceuticals labeled with 223 Ra, 111 In, 131 I and 177 Lu 183
Safety, effectiveness and haematological toxicity of 223Radichloride: a single Centre experience 183
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 182
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 182
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 182
Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism 182
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 182
A model to evaluate S values for beta-gamma emitting radionuclides in cubic voxels 180
A potentially misleading finding at somatostatin receptor scintigraphy: focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions 180
ACCUMULO DI RADIOIODIO IN MIELOMENINGOCELE SECONDARIO A SPINA BIFIDA OCCULTA: PRIMA EVIDENZA DI CONDIZIONE SIMULANTE UNA METASTASI VERTEBRALE DI CARCINOMA DIFFERENZIATO DELLA TIROIDE 179
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 179
A simplified method for kidney dosimetry in Lu-177 therapies based on single SPECT-CT and multiple external probe measurements 179
Clinico-laboratory response and haematological toxicity in patients undergoing therapy with 223RA-dichloride 178
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 177
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 177
Effectiveness, safety and haematological toxicity of 223Ra-Cl2: a single centre experience 177
Gastric motility disorders in patients operated on for esophageal atresia and tracheoesophageal fistula: Long-term evaluation 175
Recombinant erythropoietin and hypertension 175
The 14CO2 urea breath test for Helicobacter pylori infection 174
A Monte Carlo study of small-scale dosimetry in capillary vessels during internal radionuclide therapies with 223Ra, 111In, 131I and 177Lu 174
Totale 25.486
Salva come PNG Salva come JPEG
Categoria #
all - tutte 238.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 238.028
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.787 0 0 0 0 154 34 199 177 39 521 483 1.180
2022/20239.151 745 986 441 737 699 918 131 503 3.610 61 226 94
2023/20243.491 196 332 205 284 247 655 144 232 104 418 209 465
2024/202512.709 322 295 400 853 708 480 519 2.388 2.794 828 1.241 1.881
2025/202631.118 1.752 2.007 2.485 2.000 2.439 6.718 3.624 3.837 3.816 1.385 489 566
2026/20275.206 509 1.655 1.267 1.640 135 0 0 0 0 0 0 0
Totale 72.762